Tinib Antineoplastic Drugs

Tinib antineoplastic drugs are a major class of targeted cancer therapies that inhibit dysregulated tyrosine kinases or serine/threonine kinases involved in tumor growth, angiogenesis, and metastasis. Represented by imatinib, erlotinib, gefitinib, sunitinib, sorafenib, and numerous next-generation inhibitors, these APIs block oncogenic signaling pathways such as EGFR, VEGFR, PDGFR, BCR-ABL, ALK, and RET. Their precision targeting enables high efficacy with reduced systemic toxicity compared to traditional chemotherapy. Tinib drugs are widely used in leukemia, lung cancer, renal cancer, gastrointestinal stromal tumors, and melanoma. Resistance caused by kinase mutations has led to the development of multi-targeted and mutation-specific inhibitors, making tinibs a cornerstone of precision oncology.

(2R,6S,12Z,13aS,14aR,16aS)-6-[[(Cyclopentyloxy)carbonyl]amino]-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydro-2-[[7-methoxy-8-methyl-2-[2-[(1-methylethyl)amino]-4-thiazolyl]-4-quinolinyl]oxy]-5,16-dioxocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxylic acid CAS NO 849022-30-6

Unit Price:Get Price

CAS No.:849022-30-6

Grade:Pharmacy Grade

Content:99.90%

Packaging:Customizable

Inquiry Chat Now

Ponatinib CAS NO 943319-70-8

Unit Price:Get Price

CAS No.:943319-70-8

Grade:Pharmacy Grade

Content:99.90%

Packaging:Customizable

Inquiry Chat Now

Azd-6244 CAS NO 943332-08-9

Unit Price:Get Price

CAS No.:943332-08-9

Grade:Pharmacy Grade

Content:99.90%

Packaging:Customizable

Inquiry Chat Now

Jnj-38877605 CAS NO 943540-74-7

Unit Price:Get Price

CAS No.:943540-74-7

Grade:Pharmacy Grade

Content:99.90%

Packaging:Customizable

Inquiry Chat Now

Go to Page

GO